首页 | 本学科首页   官方微博 | 高级检索  
检索        

替吉奥联合奥沙利铂治疗中晚期老年胃癌的疗效及对组织中FOXP1和Ki67表达的影响
引用本文:田红旭,陈希,牛磊萍,戚林林,魏林方.替吉奥联合奥沙利铂治疗中晚期老年胃癌的疗效及对组织中FOXP1和Ki67表达的影响[J].实用癌症杂志,2022(2):296-299,304.
作者姓名:田红旭  陈希  牛磊萍  戚林林  魏林方
作者单位:河南省郑州颐和医院
基金项目:河南省医学科技攻关计划(联合共建)项目(编号:LHGJ20191160)。
摘    要:目的 探究替吉奥联合奥沙利铂治疗中晚期老年胃癌的疗效及对组织中FOXP1和Ki67表达的影响.方法 选取76例中晚期老年胃癌患者作为研究对象,随机分为对照组(n=38)和观察组(n=38).观察组患者用替吉奥与奥沙利铂治疗,对照组患者用卡培他滨与奥沙利铂治疗,比较2组临床疗效、不良反应、肿瘤标志物水平及组织中FOXP1...

关 键 词:替吉奥  中晚期老年胃癌  疗效  FOXP1  Ki67

Efficacy of Tiggio Combined with Oxaliplatin in the Treatment of Advanced Gastric Cancer in the Elderly and Its Effect on the Expression of FOXP1 and Ki67 in Tissues
Institution:(Zhengzhou Yihe Hospital,Zhengzhou,450000)
Abstract:Objective To explore the efficacy of Tiggio combined with oxaliplatin in the treatment of advanced gastric cancer in the elderly and its effect on the expression of FOXP1 and Ki67 in tissues.Methods 76 patients with advanced gastric cancer were selected as the research objects, and they were randomly divided into the control group(n=38) and the observation group(n=38).Patients in the observation group were treated with ticgio and oxaliplatin, and patients in the control group were treated with capecitabine and oxaliplatin.The clinical efficacy, adverse reactions, tumor marker levels and the levels of FOXP1 and Ki67 in the tissues were compared between the 2 groups.Results After treatment, the remission rate and total effective rate of the observation group were significantly higher than those of the control group(P<0.05);during treatment, the probability of vomiting and diarrhea in the observation group was significantly lower than that of the control group(P<0.05),and the other differences were not statistically significant(P>0.05).There was no difference in the levels of each index between the 2 groups before treatment(P>0.05).After treatment, serum MMP-9,MMP-2,CA125 and CEA in the control group and the observation group were significantly lower than before treatment(P<0.05).The index of the group was significantly higher than that of the observation group(P<0.05);the expression levels of FOXP1 and Ki67 in the tissues of the patients before treatment were not significantly different(P>0.05).After treatment, the low expression rate of FOXP1 in the tissues of the observation group and the control group was significantly reduced(P<0.05),the low expression rate of FOXP1 in the control group was higher than that in the observation group(P<0.05),and the high expression rate of Ki67 in the tissues of the control group was significantly higher than that in the observation group(P<0.05).Conclusion Tiggio combined with oxaliplatin has a certain effect on elderly patients with advanced gastric cancer, and can reduce the expression levels of FOXP1 and Ki67.
Keywords:Tiggio  Advanced gastric cancer in the elderly  Curative effect  FOXP1  Ki67
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号